To provide a comprehensive overview of the emerging role of periostin, an extracellular matrix protein, as a key component in the development, diagnosis, and treatment of patients with chronic rhinosinusitis.
Data Sources
Medline database.
Review Methods
A state of the art review was performed targeting English-language studies investigating the role of periostin in cardiopulmonary, neoplastic, and inflammatory diseases, with emphasis on recent advances in the study of periostin in chronic rhinosinusitis.
Conclusions
Periostin has emerged as a novel biomarker and therapeutic target for numerous human pathologies, including cardiac, pulmonary, and neoplastic disease. The upregulation of periostin in chronic rhinosinusitis suggests the potential for similar roles among patients with sinonasal disease.
Implications for Practice
Chronic rhinosinusitis is a widespread disease with major clinical and societal impact. A critical limitation in the current treatment of patients with chronic rhinosinusitis is the absence of clinically relevant biomarkers to guide diagnosis and treatment selection. A review of the literature supports a likely role of periostin as a biomarker of chronic rhinosinusitis, as well as a novel therapeutic target in the future treatment of patients with sinonasal disease.
ConwaySJIzuharaKKudoYet al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014;71:1279-1288.
2.
StankovicKMGoldszteinHRehDDPlattMPMetsonR. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope. 2008;118:881-889.
3.
IshidaAOhtaNSuzukiYet al. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int. 2012;61:589-595.
4.
HoriuchiKAmizukaNTakeshitaSet al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239-1249.
5.
Kruzynska-FrejtagAMachnickiMRogersRMarkwaldRRConwaySJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev. 2001;103:183-188.
6.
BlanchardCMinglerMKMcBrideMet al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008;1:289-296.
7.
OkuEKanajiTTakataYet al. Periostin and bone marrow fibrosis. Int J Hematol. 2008;88:57-63.
8.
WantanasiriPSatirapojBCharoenpitakchaiMAramwitP. Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients. Lupus. 2015;24:835-845.
9.
KatsuragiNMorishitaRNakamuraNet al. Periostin as a novel factor responsible for ventricular dilation. Circulation. 2004;110:1806-1813.
10.
BaoSOuyangGBaiXet al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004;5:329-339.
11.
McSharryCJohnstoneS. Periostin as a biomarker of airway inflammation. Pol Arch Med Wewn. 2016;126:118-120.
12.
KrouseJHVelingMCRyanMWet al. Executive summary: asthma and the unified airway. Otolaryngol Head Neck Surg. 2007;136:699-706.
13.
ZhangWHubinGEndamLMAl-MotSFilali-MouhimADesrosiersM. Expression of the extracellular matrix gene periostin is increased in chronic rhinosinusitis and decreases following successful endoscopic sinus surgery. Int Forum Allergy Rhinol. 2012;2:471-476.
14.
ShionoOSakumaYKomatsuMet al. Differential expression of periostin in the nasal polyp may represent distinct histological features of chronic rhinosinusitis. Auris Nasus Larynx. 2015;42:123-127.
15.
WangMWangXZhangNet al. Association of periostin expression with eosinophilic inflammation in nasal polyps. J Allergy Clin Immunol. 2015;136:1700-1703.e1-e9.
16.
EbenezerJAChristensenJMOliverBGet al. Periostin as a marker of mucosal remodelling in chronic rhinosinusitis. Rhinology. 2017;55:234-241.
17.
MaxfieldAZLandeggerLDBrookCDet al. Periostin as a biomarker for nasal polyps in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2018;158:181-186.
18.
DainesSMWangYOrlandiRR. Periostin and osteopontin are overexpressed in chronically inflamed sinuses. Int Forum Allergy Rhinol. 2011;1:101-105.
19.
JonstamKWestmanMHoltappelsGHolwegCTJBachertC. Serum periostin, IgE, and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2017;140:1705-1708.e3.
20.
TakeshitaSKikunoRTezukaKAmannE. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294:271-278.
21.
TakayamaGArimaKKanajiTet al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118:98-104.
22.
KiiINishiyamaTLiMet al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem. 2010;285:2028-2039.
23.
NorrisRADamonBMironovVet al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem. 2007;101:695-711.
24.
MaruhashiTKiiISaitoMKudoA. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem. 2010;285:13294-13303.
25.
LauryAMHilgarthRNusratAWiseSK. Periostin and receptor activator of nuclear factor κ-B ligand expression in allergic fungal rhinosinusitis. Int Forum Allergy Rhinol. 2014;4:716-724.
26.
IzuharaKArimaKOhtaSSuzukiSInamitsuMYamamotoK. Periostin in allergic inflammation. Allergol Int. 2014;63:143-151.
27.
SeshadriSLuXPurkeyMRet al. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2015;136:1548-1558.e7.
28.
DornGW. Periostin and myocardial repair, regeneration, and recovery. N Engl J Med. 2007;357:1552-1554.
29.
ZhaoSWuHXiaWet al. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol. 2014;63:373-378.
30.
IekushiKTaniyamaYAzumaJet al. Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension. 2007;49:1409-1414.
31.
KimJBPorrecaGJSongLet al. Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science. 2007;316:1481-1484.
32.
KühnBdel MonteFHajjarRJet al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962-969.
33.
OkaTXuJKaiserRAet al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007;101:313-321.
34.
GuanJLiuW-QXingM-Qet al. Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan. BMC Cardiovasc Disord. 2015;15:90.
35.
PfefferMABraunwaldEMoyéLAet al; SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.
36.
SolomonSDSkaliHAnavekarNSet al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005;111:3411-3419.
37.
MatsusakaMKabataHFukunagaKet al. Phenotype of asthma related with high serum periostin levels. Allergol Int. 2015;64:175-180.
38.
KanemitsuYMatsumotoHIzuharaKet al. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol. 2013;132:305-312.e3.
39.
KimM-AIzuharaKOhtaSet al. Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2014;113:314-320.
40.
JiaGEricksonRWChoyDFet al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 2012;130:647-654.e10.
41.
WoodruffPGModrekBChoyDFet al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388-395.
42.
IzuharaKOhtaSOnoJ. Using periostin as a biomarker in the treatment of asthma. Allergy Asthma Immunol Res. 2016;8:491-498.
43.
CorrenJLemanskeRFHananiaNAet al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088-1098.
44.
HananiaNAWenzelSRosénKet al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013;187:804-811.
45.
HananiaNAKorenblatPChapmanKRet al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2016;4:781-796.
46.
BenQWZhaoZGeSFZhouJYuanFYuanYZ. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer. Int J Oncol. 2009;34:821-828.
47.
LiWGaoPZhiYet al. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res. 2015;16:57.
48.
KudoYSiriwardenaBSMSHatanoHOgawaITakataT. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol. 2007;22:1167-1174.
49.
MoniuszkoTWincewiczAKodaMDomysławskaISulkowskiS. Role of periostin in esophageal, gastric and colon cancer. Oncol Lett. 2016;12:783-787.
50.
VardakiICederSRutishauserDBaltatzisGFoukakisTPanaretakisT. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Oncotarget. 2016;7:74966-74978.
51.
PlattMPSolerZMKaoS-YMetsonRStankovicKM. Topographic gene expression in the sinonasal cavity of patients with chronic sinusitis with polyps. Otolaryngol Head Neck Surg. 2011;145:171-175.
52.
MiłońskiJZielińska-BliźniewskaHPrzybyłowskaKet al. Significance of cyclooxygenase-2 (COX-2), periostin (POSTN) and interleukin-4 (IL-4) gene expression in the pathogenesis of chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2015;272:3715-3720.
53.
YangHWParkJHShinJMLeeHM. Glucocorticoids ameliorate periostin-induced tissue remodeling in chronic rhinosinusitis with nasal polyps [published online September10, 2018]. Clin Exp Allergy. doi:10.1111/cea.13267
54.
KimDWKulkaMJoAet al. Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps. J Allergy Clin Immunol. 2017;139:1692-1695.e6.
55.
KimuraHKonnoSNakamaruYet al. Sinus computed tomographic findings in adult smokers and nonsmokers with asthma: analysis of clinical indices and biomarkers. Ann Am Thorac Soc. 2017;14:332-341.
56.
XuMChenDZhouHZhangWXuJChenL. The role of periostin in the occurrence and progression of eosinophilic chronic sinusitis with nasal polyps. Sci Rep. 2017;7:9479.
57.
KimDKKangSIKongIGet al. Two-track medical treatment strategy according to the clinical scoring system for chronic rhinosinusitis. Allergy Asthma Immunol Res. 2018;10:490-502.
58.
WuDMuellerSKNoceraALFinnKLibermannTABleierBS. TREM-1 neutrophil activation pathway is suppressed in eosinophilic nasal polyps. Am J Rhinol Allergy. 2018;32:359-368.
59.
XuMZhangWChenDZhouHChenL. Diagnostic significance of serum periostin in eosinophilic chronic sinusitis with nasal polyps. Acta Otolaryngol. 2018;138:387-391.
60.
QinZLiXCaiXet al. Periostin: a novel biomarker for chronic rhinosinusitis. B-ENT. 2016;12:305-313.
61.
NinomiyaTNoguchiEHarunaTet al. Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps. Sci Rep. 2018;8:11450.
62.
WuDMuellerSKNoceraALFinnKLibermannTABleierBS. Axonal guidance signaling pathway is suppressed in human nasal polyps. Am J Rhinol Allergy. 2018;32:208-216.
63.
GevaertEZhangNKryskoOet al. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J Allergy Clin Immunol. 2017;139:1849-1860.e6.
64.
MorshedMYousefiSStöckleCSimonHUSimonD. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy. 2012;67:1127-1137.
65.
KimS-WKimJHJungMHet al. Periostin may play a protective role in the development of eosinophilic chronic rhinosinusitis with nasal polyps in a mouse model. Laryngoscope. 2013;123:1075-1081.
66.
HurDGKhalmuratovaRAhnSKHaYSMinYG. Roles of periostin in symptom manifestation and airway remodeling in a murine model of allergic rhinitis. Allergy Asthma Immunol Res. 2012;4:222-230.
67.
BrookCDMaxfieldAZStankovicKMetsonRB. The impact of angiotensin-modulating antihypertensives on time interval to revision surgery for nasal polyps. Otolaryngol Head Neck Surg. 2016;155:1046-1052.
68.
IzuharaKArimaKOhtaSSuzukiS. Periostin in allergic inflammation. Allergol Int. 2014;63:143-151.
69.
DennisSKLamKLuongA. A review of classification schemes for chronic rhinosinusitis with nasal polyposis endotypes. Laryngoscope Investig Otolaryngol. 2016;1:130-134.
70.
KimDKJinHREunKMet al. Non-eosinophilic nasal polyps shows increased epithelial proliferation and localized disease pattern in the early stage. PloS One. 2015;10:e0139945.
71.
De SchryverEDeryckeLCalusLet al. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology. 2017;55:152-160.
72.
WardzyńskaAMakowskaJSPawełczykMPiechota-PolańczykAKurowskiMKowalskiML. Periostin in exhaled breath condensate and in serum of asthmatic patients: relationship to upper and lower airway disease. Allergy Asthma Immunol Res. 2017;9:126-132.
73.
WanXCWoodruffPG. Biomarkers in severe asthma. Immunol Allergy Clin North Am. 2016;36:547-557.
74.
Caswell-SmithRHoskingACrippsTet al. Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease. Clin Exp Allergy. 2016;46:1303-1314.
75.
AsanoTKanemitsuYTakemuraMet al. Serum periostin as a biomarker for comorbid chronic rhinosinusitis in patients with asthma. Ann Am Thorac Soc. 2017;14:667-675.
76.
BerryABusseWW. Biomarkers in asthmatic patients: has their time come to direct treatment?J Allergy Clin Immunol. 2016;137:1317-1324.
77.
BayesHKCowanDC. Biomarkers and asthma management: an update. Curr Opin Allergy Clin Immunol. 2016;16:210-217.
78.
WoodruffPGBousheyHADolganovGMet al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007;104:15858-15863.
79.
IzuharaKNunomuraSNanriYet al. Periostin in inflammation and allergy. Cell Mol Life Sci. 2017;74:4293-4303.
80.
MendelsohnDJeremicGWrightEDRotenbergBW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120:162-166.
81.
De AlbuquerqueDASaxenaVAdamsDEet al. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int. 2004;65:846-859.
82.
TsaiMKJanRLLinCHet al. Suppressive effects of imidapril on Th1- and Th2-related chemokines in monocytes. J Investig Med. 2011;59:1141-1146.
83.
ShenLMoHCaiLet al. Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. Shock. 2009;31:500-506.
84.
OrecchiaPConteRBalzaEet al. Identification of a novel cell binding site of periostin involved in tumour growth. Eur J Cancer. 2011;47:2221-2229.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
